Faculty – 8th Patient Adherence and Access Summit

Hayden Bosworth, Ph.D.
Professor in Medicine, Professor in Psychiatry and Behavioral Sciences, DUKE UNIVERSITY

view speaker profile

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) that elimination of healthcare disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (this annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to improve adherence and reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and involving various members of the healthcare system (e.g., pharmacists and nurses). He has led more than 30 trials and participated in another 50, resulting in more than 275 peer-reviewed publications and four books. This work has been or is being implemented in multiple arenas, including pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser healthcare system, and Veterans Affairs. He will talk about the state of medication adherence, including population and patient-centered methods for medication adherence, the role of policy and the potential for behavioral economics, and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Kelly Conway, Patient Advocate, Rheumatoid Arthritis Health Activist, INTERNATIONAL FOUNDATION FOR AUTOIMMUNE ARTHRITIS

Kelly Conway

Rheumatoid Arthritis Health Activist and Patient Advocate

view speaker profile

Kelly Conway is a patient living with Rheumatoid Arthritis/Polyarticular Arthritis, Graves Disease and fibromyalgia since 2000. She began volunteering with the International Autoimmune Arthritis Movement in 2009 and eventually co-founded the International Autoimmune Arthritis Foundation (IFAA) in 2013. Kelly met with senators and congressmen while participating in “Advocates for Arthritis” on Capitol Hill in 2013 with the American College of Rheumatology. She received a WEGO Health Activist Best-in-Team Award in 2012 as a part of IFAA, and was an individual finalist for Health Activist Hero in 2014. Professionally, Kelly is a speech-language pathologist specializing in autism and augmentative/alternative communication in the Philadelphia area.

Penney Cowan

view speaker profile

Penney Cowan is the founder and CEO of the American Chronic Pain Association. Over the past 37 years, Ms. Cowan has been an outspoken advocate and consumer representative for pain issues; contributed to numerous books, videos and websites; and consulted on the development of several pain management programs. Ms. Cowan is a recognized speaker advocating a multidisciplinary approach to pain management. Currently she serves on the Board of the American Chronic Pain Association and the International Alliance of Patient Organizations.

Jamie Foehl
Senior Applied Researcher, DUKE UNIVERSITY

view speaker profile

Jamie Foehl is a Senior Applied Researcher at The Center for Advanced Hindsight at Duke University. Jamie applies behavioral economics to “the real world.” She conducts field research with partner organizations to develop and test behaviorally informed interventions. Jamie’s work is focused on helping people make better decisions about their health and money.

Brenda Hawkes
Senior Manager, Patient Advocacy, DIPLOMAT

view speaker profile

Brenda Hawkes is the senior manager of patient advocacy at Diplomat. She leads Diplomat’s efforts for patient advocacy by reaching out to support groups nationwide, teaching empathy training to fellow employees and keeping a keen eye on what patients need for their healthcare. Within Diplomat Brenda serves as the “voice of the patient” by always reminding the different business areas that patients hear and think differently than sales people or clinicians.

Brenda has more than 19 years of experience working in leadership, fundraising and program development. Before working at Diplomat, she established and served as the executive director for Our Promise Cancer Resources, a 501c3 organization that provides non-medical support to cancer patients and their families in south-central Arkansas. Additionally, Brenda has extensive background in community relations and developing collaborative opportunities between different stakeholders.

From personal experience, Hawkes brings an intimate understanding of what it means to be a patient. In 2006, Brenda was diagnosed with stage III triple negative breast cancer; she faced chemotherapy, radiation and nine surgeries, and is now a survivor. During this time she also found she has the BRCA1 mutation. She also has been a caregiver, for her husband, David, who underwent treatment for colon cancer in 2002.

As a survivor and patient advocate, Brenda is a testament to the need for patient support, and to the power of care and hope. She and her husband live in Fenton, MI and are proud parents of two daughters, Meghan and Erin.

Debra Hays
Consultant, Center for Innovative Customer Experience (ICE), ELI LILLY

view speaker profile

Debra Hays serves as Consultant on the Innovative Customer Experience team at Lilly USA. Since joining Lilly USA in 2015, she has led efforts to leverage behavioral science theory to improve adherence through marketing touch points across therapeutic areas. Prior to her time at Lilly USA, she served 13 years with Community Health Network, an integrated eight-hospital network, in central Indiana. During her tenure there, she started as a physical therapist then assumed multiple leadership roles, including Director of Physician Recruitment and Referral Development and Director of Physician Access. In these roles, she led network growth initiatives by incorporating physician market analysis and outreach, recruitment methodology, and performance improvement processes.

Debra completed her physical therapy training at Indiana University and her master of business administration at Indiana University’s Kelley School of Business.

Dr. Donney John

view speaker profile

Dr. John is the Chief Clinical Officer leading our Hospital Transition in Care and our Employer Solutions programs. He is a practicing pharmacist, healthcare consultant, entrepreneur and patient advocate. He also serves as the Executive Director of NOVA ScriptsCentral, a nonprofit pharmacy that provides medications to uninsured patients in the Northern Virginia area.

Dr. John has considerable expertise in the areas of precision medicine, patient engagement, population health management, transition in care and mobile health technology solutions. He serves as a medical advisor for a variety of companies focused on health/wellness, patient engagement and medication adherence. Dr. John is also the CEO and founder of Urban Medical Solutions, LLC, a consulting company focused on improving health outcomes through clinical workflow and technology integration.

Dr. John has previously worked at a very large population health management startup, where he actively participated in the development of clinical services and the integration of technology solutions in improving health outcomes. Dr. John has also worked in academia serving as an Assistant Professor of Pharmacy Practice at Massachusetts College of Pharmacy & Health Sciences, where he developed innovative ambulatory care practice sites within federally qualified community health centers. He has worked to train healthcare professionals in the areas of health literacy and cultural competency in order to address health disparities.

Dr. John holds a Doctor of Pharmacy degree from St. John’s University in Queens, New York and has completed a pharmacy residency with Massachusetts College of Pharmacy and Health Sciences.


Eric Katz, J.D.

view speaker profile

Eric Katz, J.D., is President of Pharma & Healthcare Dimensions, applying three decades in health law and policy to help clients understand FDA, Medicare and other government regulations.

Eric builds strategies for drugs advancing from FDA approval to insurance coverage and reimbursement. He monitors health reform laws and other influences on regulatory compliance. He analyzes Washington developments, Wall Street perspectives and research developments.

At CMS, Eric helped develop coverage decisions and worked with the Medicare prescription drug benefit and managed care reforms. He served as Executive Director of the US Advisory Committee on the FDA.

Ira Klein, M.D., MBA, FACP
Senior Director of Healthcare Quality Strategy, Strategic Customer Group, JANSSEN PHARMACEUTICALS

view speaker profile

Ira Klein, M.D., MBA, FACP, is the Senior Director of Health Care Quality Strategy in the Strategic Customer Group of J&J Health Care Services, advancing value-based solutions for market access. He previously spent 10 years at Aetna, was the National Medical Director for Clinical Thought Leadership, founded the Oncology Solutions team, and held a variety of other roles.

Prior to Aetna, he led the quality, cost and care management area for the Bayshore Community Health System. Previous to that, he was CMO of Elderplan, serving the frail elderly in NYC. He began his career practicing internal medicine for seven years at Robert Wood Johnson Medical School as Assistant Professor in the Division of General Internal Medicine.

Ira holds a B.S. from Rutgers University College of Pharmacy, an M.D. from University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School, and an MBA from Rutgers University.

Sarah Krüg

view speaker profile

Sarah Krug is CEO/Executive Director of CANCER101, a patient advocacy organization she has been on the board of for two years, in a quest to help patients and caregivers navigate their cancer journey. Driven by the passion to make an impact in patient care and engagement, Sarah has held a variety of roles within healthcare.

She previously held the position of Global Education Director in the Medical Education Group at Pfizer, where she focused on establishing global healthcare improvement strategies and medical education standards worldwide. She also established the Global Investigator-Initiated Research Program at Pfizer. Prior to joining Pfizer in 2001, Sarah spearheaded the development of the pediatric disease management clinical pathways and conducted clinical research at Memorial Sloan Kettering Cancer Center. She is also on the board of the Cancer Patient Education Network, where she serves as Research Chair.

Dr. Zeshan Mahmood
Clinical Director, Healthcare Strategy, PHARMACIST PARTNERS

view speaker profile

Zeshan is leading Pharmacist Partners’ Home Care Solutions, which provides medication counseling to senior patients who are aging in place — at home. He is also a practicing pharmacist for Walgreens, licensed in Washington, DC and Virginia.

In addition, Zeshan also works on patient education and outreach initiatives with NovaScripts Central, a nonprofit pharmacy that provides free medications to uninsured and low-income patients.

Zeshan completed several clinical internships at healthcare organizations in the Northern Virginia area focusing on population health, health policy, and outcomes-based care. He was involved with a number of research and patient-driven initiatives aimed at improving patient outcomes through medication reconciliation, patient education, and the reduction of rates of Clostridium Difficile infections and antibiotic resistance patterns at the Inova Health System.

He obtained his Doctor of Pharmacy degree from Virginia Commonwealth University and also has his B.S. in neuroscience from George Mason University.

Richard Murray
Vice President and Deputy Chief Patient Officer, MERCK

view speaker profile

Dr. Murray joined Merck & Co., Inc. in November 1994, and he was promoted to Vice President, External Medical and Scientific Affairs, in August of 2007. Since June of 2016, he has held the position of Vice President and Deputy Chief Patient Officer at Merck. In that role, he leads a cross-divisional and global effort to increase engagement with patients in all aspects of the firm’s business. Dr. Murray graduated from Clark University (Worcester, Massachusetts) with an A.B. in psychology and an M.A. in chemistry. He graduated from Howard University College of Medicine (Washington, DC) and subsequently was an intern, resident, Chief Medical Resident, and Pulmonary and Critical Care Fellow at the University of Pennsylvania in Philadelphia. He is Board Certified in Internal Medicine and Pulmonary Diseases, and is a Fellow of the American College of Physicians. He currently serves on the Board of the Foundation of the American Thoracic Society, and is also on the Board of The Asthma and Allergy Foundation of America and Project HOPE.

Laurie Myers
Global Health Literacy Director, MERCK & CO., INC.

view speaker profile

Laurie Myers leads health literacy efforts globally for Merck Sharp & Dohme, Inc. For six years, she has focused on the integration of health literacy externally and across divisions at Merck. Key projects include patient labeling, packaging, clinical trials, Instructions for Use and patient education. Laurie actively participates on several external projects, including the NAS Health Literacy Roundtable; is co-chair of the Multi-Regional Clinical Trials Center of Harvard & Brigham and Women’s aggregate return of results group; and is an invited member of the EMA lay summaries working group. Laurie has worked to include respondents with low health literacy into patient labeling research, which earned her and her team the national IHA health literacy award in research in May 2016. She has co-authored several publications.

Andrew Peterson, PharmD, Ph.D., FCPP
Dean, Mayes College of Healthcare Business and Policy, UNIVERSITY OF THE SCIENCES IN PHILADELPHIA

view speaker profile

Andrew Peterson, PharmD, Ph.D., FCPP, is the John Wyeth Dean of the Mayes College and Professor of Health Policy and Clinical Pharmacy at University of the Sciences in Philadelphia and was formerly the Chair of the Department of Pharmacy Practice/Pharmacy Administration. He is also a Fellow in the College of Physicians of Philadelphia.

Before joining USciences in 1996, he was an Assistant Director of Pharmacy and Clinical Services at Thomas Jefferson University Hospital and an Associate Director of Pharmacy, Drug Information and Clinical Services at Crozer-Chester Medical Center.

Highly regarded in the fields of pharmacy management and health policy, Dr. Peterson has more than 25 years of research experience in pharmacy management; medication adherence; health policy; and, more recently, substance use disorders and healthcare professionals. His accomplishments are wide-ranging: He has produced a large body of research and scholarly work, created innovative programming, and secured significant grant dollars.

Known for his commitment to mentoring others and fostering success, his recognitions include several awards for excellence in teaching and for learning innovation.

Dr. Peterson speaks at conferences around the world on issues related to medication adherence, health policy and pharmacy. He is co-author of an authoritative text for mid-level practitioners: Advanced Pharmacotherapeutics: A Practical Approach published in 2016, editor of the book Leadership and Management in Pharmacy Practice, and a contributor to numerous peer publications. His journal reviews include the American Journal of Hospital/Health System Pharmacy, the Journal of the American Pharmaceutical Association, the Journal of the American Medical Association, and Lancet.

Active in the academic and research communities, Dr. Peterson has served on the boards of many professional organizations. He is also a member of Delta Mu Delta International Society in Business and the Phi Lamda Sigma Pharmacy Leadership Society.

Dr. Peterson earned his PharmD from Virginia Commonwealth University and his Ph.D. in health policy at USciences. He also completed an Advanced Residency in hospital pharmacy administration at Jefferson Medical College of Thomas Jefferson University and a Residency in hospital pharmacy practice from Rush-Presbyterian St. Luke’s Medical Center. He lives in suburban Philadelphia.

Liz Presson
Digital Media and Community Experience, OTICON MEDICAL

view speaker profile

Liz Presson works at the intersection of patient engagement, innovation, and digital strategy with pharmaceutical and medical device companies. She’s led innovation initiatives for Fortune 500 Pharma organizations, built advocacy programs for medical device companies that doubled the bottom line, and has helped transform influential healthcare organizations into digital leaders. Liz takes the stage at conferences like Stanford’s Medicine X, Technori, World Maker Faire, Internet Summit, and others. She contributes articles on company culture, entrepreneurship, and technology to publications like Fast Company, Forbes, Inc., and Mashable.

Jodi Seidler

Joint Pain and Hip Replacement Advocate

view speaker profile

Jodi Seidler of 2 Hip Productions is the Founder of HipsterClub.com, Author and ePatient Spokesperson. She is a WEGO Health Advocate, an Arthritis Foundation Ambassador and an Advocate for AARP.  In her double HIPster status, Jodi educates, supports and inspires people of all ages through the joint replacement process because it was SO powerful for her!

Olayinka O. Shiyanbola, B.Pharm, PhD.
Assistant Professor, Division of Social and Administrative Sciences, School of Pharmacy, UNIVERSITY OF WISCONSIN, MADISON

view speaker profile

Olayinka (Yinka) Shiyanbola is an Assistant Professor in the Social and Administrative Sciences Division at the University of Wisconsin-Madison School of Pharmacy. She received her Bachelor of Pharmacy (B.Pharm) degree from the University of Ibadan in Nigeria and her Ph.D. in Pharmaceutical Socioeconomics from the University of Iowa.

Dr. Shiyanbola’s research program focuses on the utilization of patient perspectives to improve medication use, patient outcomes, and quality of care. She examines patient perceptions and roles in the quality of medication use and its impact on medication adherence, health literacy and the elimination of health disparities. Dr. Shiyanbola explores how to utilize and interweave patient illness and medicine perceptions into the development of tailored patient-centered medication use interventions. In her other areas of interests, Dr. Shiyanbola is empirically redesigning prescription warnings and is exploring how patients can utilize pharmacy quality indicators. She utilizes sociobehavioral and health psychology theories in her studies and employs both qualitative and quantitative methodological applications in her work.

Dr. Shiyanbola was a NIH Mixed Methods Research Training Scholar, a NIMHD Health Disparities Research Institute Scholar, and is currently a NIH KL2 Scholar through the UW Institute for Clinical and Translational Research.

Anindita Sinha
Director, Market Intelligence, Business Insights, Corporate and Government Customers, BAYER HEALTHCARE

view speaker profile

Anindita (Ani) Sinha is currently a Director of Business Insights, focusing on US Market Access at Bayer Healthcare. Her current role focuses on the entire specialty portfolio, spanning six different therapeutic areas. Prior to her role at Bayer, she was an Associate Director of Market Access Market Analytics at Celgene Corporation, supporting the hematology and oncology business units. Prior to Celgene, Ani spent several years at Campbell Alliance in their pricing and market access practice as well as at Navigant Consulting in their life sciences practice. Ani has an M.S. from Yale University in microbiology and a B.A. from Columbia University in biochemistry.

Elizabeth Unni, Ph.D., MBA, BPharm
Assistant Professor of Pharmaceutical Sciences, College of Pharmacy, ROSEMAN UNIVERSITY OF HEALTH SCIENCES, UTAH

view speaker profile

Elizabeth Unni is an Assistant Professor of Pharmaceutical Sciences at the Roseman University of Health Sciences College of Pharmacy in South Jordan, Utah. She is also an Adjunct Faculty with the Department of Pharmacotherapy at the University of Utah. Dr. Unni holds a Ph.D. in pharmaceutical socioeconomics from the University of Iowa, a Master in Business Administration from the University of Louisiana at Monroe and a Bachelor of Pharmacy degree from India. Dr. Unni has several publications in peer-reviewed journals and has also presented her research at various national and international conferences. Her research interest is in chronic disease management with special emphasis on medication adherence, health literacy, patient beliefs and patient education.

Dr. Larry Westfall
Advisor Value-Based Care, PHARMACIST PARTNERS


view speaker profile

Larry is spearheading innovative Hospital and Home Care Solutions for Pharmacist Partners’ clients. He is also the COO of ScopiaRx, one of PharmacistPartner’s corporate partners.

For several years prior to joining Pharmacist Partners, Larry was Director, Healthcare Quality Alliances for the Strategic Customer Group within Johnson & Johnson Health Care Systems. He was part of a team responsible for developing an understanding across Janssen Pharmaceuticals/J&J of the changing dynamics within the US healthcare system, and working across the organization to develop strategies to align company offerings with the needs of current and evolving healthcare delivery and payment models.

Prior to this role, Larry held positions within J&J as the National Director, Strategic Alliances in the Health, Policy, Advocacy & Quality division and the Director of Quality Management for the Johnson & Johnson Institutional Franchise where Larry was responsible for providing franchise-specific strategic quality planning and perspective on current health system practices and future healthcare environment strategies. During his tenure in this position, Larry was appointed and served as a Member of the NQF National Priority Partnerships’ Care Coordination Workgroup.

Prior to joining Johnson & Johnson in 2005, Larry held a variety of leadership positions with Aventis Pharmaceuticals. Larry received his B.S. in pharmacy and Doctor of Pharmacy degrees from the University of Maryland and, prior to his career in the pharmaceutical industry, held several senior management pharmacy positions in the hospital, home care and long-term care segments. In addition, Larry has held faculty appointments at the University of Maryland School of Pharmacy and George Washington University School of Medicine, where he taught geriatric pharmacotherapy.

MarlaJan Wexler
Creator/Author, LUCK FUPUS

Patient Leader

view speaker profile

MarlaJan Wexler is 35 years old, was born with a complex congenital heart defect and had four open-heart surgeries by the time she was six. She went from pediatric cardiac ICU patient to pediatric cardiac ICU nurse until being diagnosed with systemic lupus erythematosus (lupus). Due to complications from the disease, she was forced to put her nursing career on hold. Since 2008 she’s been diagnosed with lupus and multiple overlapping autoimmune diseases, cervical cancer, and underwent a double mastectomy December 2014 after a lump was found in her breast.

She’s the creator and author of the blog Luck Fupus, www.luckfupus.com, where she writes about the day-to-day and long-term struggles of living with multiple chronic illnesses. She’s known for her humorous, non-sugar-coated, keep-it-real style of writing. Her blog was used as a platform to help her become a patient leader and influencer, and she now travels the country attending healthcare conferences, speaking publicly sharing her story, and educating and advocating for patients across the globe.